Aaron Kowalski, Ph.D., sat down with the Pittsburgh Post-Gazette during his stay here this month. Focusing on type 1 diabetes research and technology on the market, they talked about the importance of the Medtronic MiniMed 670G, dubbed the “artificial pancreas.”
“It’s not yet snap your fingers and you have a fully mechanical artificial pancreas,” he said. “More innovation will be beneficial.”
They went on to speak about other exciting advancements within the type 1 community, including faster acting insulins, such as Fiasp, the pursuit of other closed-loop insulin pumps and more. To read the full article, click here!